These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24551336)

  • 1. The NIH Office of Rare Diseases Research patient registry Standard: a report from the University of New Mexico's Oculopharyngeal Muscular Dystrophy Patient Registry.
    Daneshvari S; Youssof S; Kroth PJ
    AMIA Annu Symp Proc; 2013; 2013():269-77. PubMed ID: 24551336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network.
    Shimizu R; Ogata K; Tamaura A; Kimura E; Ohata M; Takeshita E; Nakamura H; Takeda S; Komaki H
    BMC Health Serv Res; 2016 Jul; 16():241. PubMed ID: 27401940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB).
    Rubinstein YR; Groft SC; Bartek R; Brown K; Christensen RA; Collier E; Farber A; Farmer J; Ferguson JH; Forrest CB; Lockhart NC; McCurdy KR; Moore H; Pollen GB; Richesson R; Miller VR; Hull S; Vaught J
    Contemp Clin Trials; 2010 Sep; 31(5):394-404. PubMed ID: 20609392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data Quality in Rare Diseases Registries.
    Kodra Y; Posada de la Paz M; Coi A; Santoro M; Bianchi F; Ahmed F; Rubinstein YR; Weinbach J; Taruscio D
    Adv Exp Med Biol; 2017; 1031():149-164. PubMed ID: 29214570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy.
    Youssof S
    Muscle Nerve; 2016 May; 53(5):694-9. PubMed ID: 26453481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.
    de Blieck EA; Augustine EF; Marshall FJ; Adams H; Cialone J; Dure L; Kwon JM; Newhouse N; Rose K; Rothberg PG; Vierhile A; Mink JW;
    Contemp Clin Trials; 2013 Jul; 35(2):48-54. PubMed ID: 23628560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The French National Registry of patients with Facioscapulohumeral muscular dystrophy.
    Guien C; Blandin G; Lahaut P; Sanson B; Nehal K; Rabarimeriarijaona S; Bernard R; Lévy N; Sacconi S; Béroud C
    Orphanet J Rare Dis; 2018 Dec; 13(1):218. PubMed ID: 30514324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and evolving rare diseases research programs at the National Institutes of Health.
    Groft SC; Rubinstein YR
    Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerating Rare Disease Drug Development: Lessons Learned from Muscular Dystrophy Patient Advocacy Groups.
    Huml RA; Dawson J; Bailey M; Nakas N; Williams J; Kolochavina M; Huml JR
    Ther Innov Regul Sci; 2021 Mar; 55(2):370-377. PubMed ID: 32974874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNER.
    Rubinstein YR; Posada de la Paz M; Mora M
    Adv Exp Med Biol; 2017; 1031():141-147. PubMed ID: 29214569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of Questions in Rare Disease Registries: The PRISM Library Project.
    Richesson RL; Shereff D; Andrews JE
    Interact J Med Res; 2012 Oct; 1(2):e10. PubMed ID: 23611924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rare Diseases Clinical Research Network Contact Registry update: features and functionality.
    Richesson RL; Sutphen R; Shereff D; Krischer JP
    Contemp Clin Trials; 2012 Jul; 33(4):647-56. PubMed ID: 22405970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of symptomatic sinus dysfunction described in oculopharyngeal muscular dystrophy. Fortuitous association or syndrome?].
    Belmihoub-Salmi S
    Ann Cardiol Angeiol (Paris); 2016 Feb; 65(1):42-4. PubMed ID: 23177757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for Improving the Quality of Rare Disease Registries.
    Kodra Y; Weinbach J; Posada-de-la-Paz M; Coi A; Lemonnier SL; van Enckevort D; Roos M; Jacobsen A; Cornet R; Ahmed SF; Bros-Facer V; Popa V; Van Meel M; Renault D; von Gizycki R; Santoro M; Landais P; Torreri P; Carta C; Mascalzoni D; Gainotti S; Lopez E; Ambrosini A; Müller H; Reis R; Bianchi F; Rubinstein YR; Lochmüller H; Taruscio D
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30081484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of rare recessive oculopharyngeal muscular dystrophy (OPMD) coexisting with hereditary neuropathy with liability to pressure palsies (HNPP).
    Marsh EA; Robinson DO
    Clin Neurol Neurosurg; 2008 May; 110(5):525-8. PubMed ID: 18358598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design.
    Youssof S; Schrader R; Bear D; Morrison L
    Neuromuscul Disord; 2015 Mar; 25(3):238-46. PubMed ID: 25500011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIH creates registry of stem cells.
    McLellan F
    Lancet; 2001 Nov; 358(9294):1706. PubMed ID: 11728559
    [No Abstract]   [Full Text] [Related]  

  • 18. The Dutch patients' perspective on oculopharyngeal muscular dystrophy: A questionnaire study on fatigue, pain and impairments.
    van der Sluijs BM; Knoop H; Bleijenberg G; van Engelen BG; Voermans NC
    Neuromuscul Disord; 2016 Mar; 26(3):221-6. PubMed ID: 26948710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Mexico's low cancer mortality using two national death registries.
    Lozano-Esparza S; Stern D; Hernández-Ávila JE; Morales-Carmona E; Mohar A; Lajous M
    Salud Publica Mex; 2020; 62(2):181-185. PubMed ID: 32237560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rare Diseases Clinical Research Network's organization and approach to observational research and health outcomes research.
    Krischer JP; Gopal-Srivastava R; Groft SC; Eckstein DJ;
    J Gen Intern Med; 2014 Aug; 29 Suppl 3(Suppl 3):S739-44. PubMed ID: 25029976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.